Onkor Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Seattle, WA .
Onkor Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Robert Allebaugh, Marketing at the company’s single location by writing to 24605 Se 9th Place, Seattle, Washington WA 98104 or by phoning (206) 694-4424. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Onkor Pharmaceuticals Inc |
Contact Person: | Robert Allebaugh, Marketing |
Address: | 24605 Se 9th Place, Seattle, Washington 98104 |
Phone Number: | (206) 694-4424 |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4242101 |
Share This Business: |
Onkor Pharmaceuticals Inc was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Robert Allebaugh, Marketing for inquiries that concern Onkor Pharmaceuticals Inc by calling the company number (206) 694-4424, as your correspondence is most welcome. Additionally, the physical location of the single location of Onkor Pharmaceuticals Inc can be found at the coordinates 47.60286,-122.32936 as well as the street address 24605 Se 9th Place in Seattle, Washington 98104.
For its online presence, you may visit Onkor Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.